PAthwAy of Dyspneic patIent in Emergency (PArADIsE)

Acute Disease Clinical Trial

— PArADIsE  

Official title:

PAthwAy of Dyspneic patIent in Emergency

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT02800122
• Other study ID #: R2016-08
• Status: Recruiting
• Start date: March 2016
• Est. completion date: October 25, 2025

Study information

• Verified date: April 2023
• Source: Central Hospital, Nancy, France
• Contact: Tahar CHOUIHED, MD, PhD
• Phone: + 33 3 83 15 73 88
• Email: t.chouihed[@]chru-nancy.fr
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This is an observational retrospective single-center study (CHRU of Nancy) in patients cared for acute dyspnea by a medical team of the emergencies of the CHRU of Nancy.

The main purpose of the study is to evaluate the outcome of patients cared for acute dyspnea by a medical team of emergencies of CHRU of Nancy.

Description:

This observational retrospective single-center study will be conducted using data from medical records, acquired as part of usual care, patients cared for acute dyspnea in the last 5 years (from the date of authorization of data processing). About 4,000 patients will be affected, including more than 800 patients with acute heart failure.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 24000
• Est. completion date: October 25, 2025
• Est. primary completion date: December 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Man or women = 18 years

• Patients with acute dyspnea cared by a medical team of the emergencies of CHRU of Nancy.

Exclusion Criteria:

• Cardiorespiratory arrest before the care by a medical team of the emergencies of the CHRU of Nancy.

Related Conditions & MeSH terms

• Acute Disease
• Dyspnea
• Dyspnea; Cardiac
• Emergencies

Locations

Country	Name	City	State
France	CHRU Nancy - Service des Urgences	Nancy

Sponsors (2)

Lead Sponsor	Collaborator
CHOUIHED Tahar	Central Hospital, Nancy, France

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	All cause in-hospital mortality		in the last 5 years
Secondary	Demographic and clinical data of patients cared by a medical team of emergencies		in the last 5 years
Secondary	Duration of total hospitalization (including emergency stay and conventional hospitalization)		in the last 5 years
Secondary	The main diagnosis of the initial hospitalization		in the last 5 years
Secondary	Rate of Brain Natriuretic Peptide (BNP)		in the last 5 years
Secondary	Administration of non-invasive ventilation and / or diuretics and / or nitrates		in the last 5 years
Secondary	Administration time of non-invasive ventilation and / or diuretics and / or nitrates		in the last 5 years
Secondary	Service type admitting the patient after the emergency care (intensive care, cardiology, intensive care cardiology, other ...)		in the last 5 years
Secondary	Admission time in a service after the emergency care		in the last 5 years
Secondary	Mortality and re-hospitalization of included patients		in the last 5 years